The Development of Preparatory Information Model in Patient with Hepatocellular Carcinoma Undergoing Transarterial Oily Chemoembolization

Abstract

This research and development purpose to develop preparatory information model in patient with hepatocellular carcinoma undergoing transarterial oily chemoembolization. Data collected during May 2021 - March 2022, the target group of the study was 30 patients with hepatocellular carcinoma  undergoing transarterial oily chemoembolization and 10 Udon Cathlab nurses. There were three steps of process development: the first step surveyed and developed model by brainstorming, the second step; try to used for preparatory information model, and the third step; evaluated the result of using this model. Instrument used in the study were 1) preparatory information model. 2)questionnaires for patient about general information, assessment forms of anxiety, the cooperation in patient with hepatocellular carcinoma and 3) questionnaires for Cathlab nurses about general information, opinion about preparatory information model. Data collection used preparatory information model in patient with hepatocellular carcinoma undergoing transarterial oily chemoembolization. Data analysis used the statistics including frequency, percentages and dependent T-test.

Results: preparatory information model in thirty patients with hepatocellular carcinoma undergoing transarterial oily chemoembolization has 4 steps: 1) made good relationships, assessment of information needs and preparing data 2) provided patients’ information via media 3) reviewed and provided additional information then replied the questions. Model implementation found that 1) patient mean anxiety score before and after from 46.4 (SD =1.5) to 36.0 (SD = 2.0) reduced with statistically significant (p<0.02) and patients also had compliance in during treatment at a highest level up to 83.33% 2) service provider (ten Cathlab nurses) agree with the develop preparatory information model in patient with hepatocellular carcinoma undergoing transarterial oily chemoembolization.